Anemia, Hemolytic

9 registered clinical trials studyying Anemia, Hemolytic — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Enrolling By Invitation	A Study to Provide Continued Access to Mitapivat for Participants Who Previously Completed an Agios-Sponsored NCT05777993	Agios Pharmaceuticals, Inc.	Phase 4
Terminated	Pyruvate Kinase (PK) Deficiency Global Longitudinal Registry: Patient-Reported Outcomes (PRO) NCT04964323	Agios Pharmaceuticals, Inc.	—
Completed	Ferumoxytol Enhanced Hyperfine Low Field Strength MRI NCT04721262	University of Pennsylvania	—
Completed	A Study to Evaluate Efficacy and Safety of AG-348 in Not Regularly Transfused Adult Participants With Pyruvate NCT03548220	Agios Pharmaceuticals, Inc.	Phase 3
Completed	A Study Evaluating the Efficacy and Safety of AG-348 in Regularly Transfused Adult Participants With Pyruvate NCT03559699	Agios Pharmaceuticals, Inc.	Phase 3
Completed	SCD-PROMIS: A Software Platform to Enhance Self-efficacy and Patient-provider Engagement for Patients With Sic NCT03006718	Julia Finkel	N/A
Unknown	Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturn NCT01760096	Institute of Hematology & Blood Diseases Hospital, China	Phase 2
Unknown	Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal H NCT01642979	Institute of Hematology & Blood Diseases Hospital, China	Phase 2
Unknown	Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic An NCT01579110	Institute of Hematology & Blood Diseases Hospital, China	Phase 2